Getting prescribed Ozempic starts with a doctor’s visit where you’ll need to show a medical reason that fits the drug’s approved uses, primarily type 2 diabetes. Ozempic is not approved for weight loss on its own, which shapes every step of the process, from which doctor you see to whether your insurance covers it. Here’s what you need to know before your appointment.
What Ozempic Is Actually Approved For
Ozempic (semaglutide) is FDA-approved for three specific uses in adults with type 2 diabetes: improving blood sugar control alongside diet and exercise, reducing the risk of heart attack, stroke, and cardiovascular death in people with established heart disease, and protecting kidney function in people with chronic kidney disease.
It is not approved for weight loss. Wegovy, which contains the same active ingredient at a higher dose, is the version marketed for weight management. This distinction matters because it affects whether your doctor can prescribe it, how your insurance handles the claim, and what hoops you may need to jump through. Some doctors do prescribe Ozempic off-label for weight loss, but insurance almost never covers it for that purpose.
Which Doctors Can Prescribe It
Any licensed physician, nurse practitioner, or physician assistant can write a prescription for Ozempic. In practice, the most common prescribers are primary care doctors and endocrinologists. If you already have a type 2 diabetes diagnosis and a primary care provider managing it, that’s the simplest starting point. Endocrinologists, who specialize in hormone and metabolic conditions, are another common route, especially if your blood sugar has been difficult to control with other medications.
If you’re looking for Ozempic specifically for weight loss, an obesity medicine specialist may be willing to discuss it, though they’ll more likely steer you toward Wegovy or another FDA-approved weight loss medication. Doctors are generally cautious about prescribing Ozempic off-label when an on-label alternative exists.
What to Prepare Before Your Appointment
Walking in prepared speeds up the process significantly. Your doctor will want to review several things before writing the prescription:
- Recent lab work. An A1C test (which measures average blood sugar over 2 to 3 months) is the most important number. Many insurers require an A1C of 7.5% or higher before approving Ozempic if you’re adding it to an existing diabetes medication. Kidney and liver function tests are also standard.
- Your medication history. Insurers typically want to see that you’ve already tried metformin and either didn’t tolerate it, had a contraindication, or didn’t get adequate blood sugar control from it alone.
- A recent eye exam. VA guidelines and some clinical protocols call for a diabetic eye exam completed within the past 12 months before starting a GLP-1 medication.
- Your full medical history. Certain conditions can disqualify you or require extra documentation. These include a personal or family history of medullary thyroid cancer, a condition called Multiple Endocrine Neoplasia syndrome type 2, a history of pancreatitis, severe gastroparesis, pregnancy, or current use of a class of diabetes drugs called DPP-4 inhibitors.
Bring a list of all your current medications and supplements. If you’ve had pancreatitis in the past but the cause has been resolved, mention that specifically, since it may not be an automatic disqualifier.
The Telehealth Option
You don’t have to go to an office. Multiple telehealth platforms now offer virtual consultations for Ozempic prescriptions. The process typically involves filling out a health questionnaire, uploading or completing lab work (A1C, kidney function, liver function), and having a video or phone consultation with a licensed clinician.
During the visit, expect questions about your diabetes history, prior medications, heart disease risk factors, and any history of thyroid disease or pancreatitis. The clinician will also ask about your diet, exercise habits, and current symptoms. If they determine Ozempic is appropriate, they’ll send the prescription to your pharmacy electronically. Follow-up visits are usually scheduled to track your response and monitor for side effects.
Telehealth works best if you already have recent lab results you can share. If you don’t, the provider will likely order labs before writing the prescription, which adds a few days to the timeline.
Getting Through Insurance Approval
Most commercial insurance plans cover Ozempic for type 2 diabetes, but nearly all require prior authorization. This means your doctor’s office submits paperwork proving you meet the insurer’s criteria before the pharmacy can fill the prescription. A typical set of requirements, based on Aetna’s policy, looks like this:
- You have a confirmed type 2 diabetes diagnosis.
- You’ve tried metformin and it either didn’t work well enough, caused side effects you couldn’t tolerate, or you have a medical reason you can’t take it.
- Alternatively, you need combination therapy and your A1C is 7.5% or higher.
- Or you have established cardiovascular disease.
If you’re already on another GLP-1 medication and switching to Ozempic, the insurer will want to see that you’ve been on a stable dose for at least 3 months and that your A1C has improved. Prior authorization can take anywhere from a few days to a couple of weeks. Your doctor’s office handles most of it, but be prepared to follow up if you don’t hear back.
If you’re seeking Ozempic purely for weight loss without a diabetes diagnosis, insurance will almost certainly deny coverage.
What It Costs Without Full Coverage
Ozempic is expensive at retail price, but there are ways to reduce what you pay. Novo Nordisk, the manufacturer, offers a savings card for people with commercial insurance that can lower your copay. You’re not eligible for this card if you have Medicare or Medicaid.
For people paying entirely out of pocket, Novo Nordisk has set pricing for uninsured patients with type 2 diabetes: $349 per month for the 0.25 mg, 0.5 mg, or 1 mg pens, and $499 per month for the 2 mg pen. These are significantly lower than the full retail cost but still represent a major ongoing expense.
Why Compounded Versions Are Risky
During Ozempic’s multi-year shortage (which the FDA declared resolved in February 2025), compounding pharmacies began making their own semaglutide products. Some of these are still on the market. The FDA has raised serious concerns about them.
Compounded semaglutide is not FDA-approved, meaning no one has verified its safety, effectiveness, or quality before it reaches you. Some compounded products use salt forms of semaglutide (like semaglutide sodium or semaglutide acetate) that are chemically different from what’s in the approved drug, and there’s no data confirming they behave the same way in your body. As of July 2025, the FDA had received 605 adverse event reports tied to compounded semaglutide. Some of these may be linked to doses that exceed the approved labeling or faster-than-recommended dose increases.
Now that the branded supply has stabilized, the FDA’s position is clear: compounded versions should only be used when the approved drug can’t meet a patient’s specific medical need. For most people, that threshold is no longer met.
Ozempic vs. Wegovy: Choosing the Right Prescription
If your primary goal is weight loss rather than blood sugar control, the more straightforward path is asking your doctor about Wegovy. Both drugs contain semaglutide, but Wegovy is approved for chronic weight management in adults with a BMI of 30 or higher (or 27 with at least one weight-related condition). Its maximum dose is also higher than Ozempic’s: 2.4 mg weekly compared to 2 mg.
Pursuing the drug that matches your actual medical need makes everything easier. Insurance is more likely to cover it, your doctor won’t be navigating off-label prescribing territory, and the dosing is optimized for your goal. If you have type 2 diabetes and want help with both blood sugar and weight, Ozempic covers both. If weight is the issue without diabetes in the picture, Wegovy is the cleaner route.